Dextrose 5% in water
Sponsors
Merck Sharp & Dohme LLC, Fayoum University Hospital, Virginia Commonwealth University, National Taiwan University Hospital, Ahi Evran University Education and Research Hospital
Conditions
Acute Coronary SyndromesAlcoholic HepatitisBacterial InfectionsCarpal Tunnel SyndromeFungal InfectionGonarthrosisHypernatremiaLateral Epicondylitis
Early Phase 1
Phase 1
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520)
CompletedNCT01075984
Start: 2010-02-23End: 2012-11-20Updated: 2017-11-13
A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants
CompletedNCT06547554
Start: 2024-09-04End: 2025-10-27Updated: 2025-11-28
Phase 2
Phase 4
Intrathecal Neostigmine for Prevention of PDPH
CompletedNCT03587441
Start: 2018-08-04End: 2019-02-10Updated: 2019-07-15
Low and High Dose Dextrose Prolotherapy in the Treatment of Lateral Epicondylitis
CompletedNCT04680936
Start: 2021-01-01End: 2022-05-21Updated: 2022-05-26
Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction in Patients With Severe Hypernatremia
CompletedNCT04949139
Start: 2021-05-01End: 2025-02-22Updated: 2025-08-29
Comparison of Ultrasound-Guided Perimeniscal Steroid and 5% Dextrose Injections in Knee Osteoarthritis
CompletedNCT06308887
Start: 2023-10-02End: 2024-03-02Updated: 2024-03-13
Unknown Phase
Corticosteroid and Repeated Dextrose Hydro-dissection for Carpal Tunnel Syndrome Patients
NCT04579783
Start: 2020-11-27End: 2022-12-31Target: 60Updated: 2021-12-15
Dextrose Effect on Postoperative Nausea and Vomiting (PONV)
CompletedNCT04726436
Start: 2021-01-25End: 2021-05-01Updated: 2021-08-30
The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome
RecruitingNCT05429827
Start: 2022-11-18End: 2025-12-31Target: 30Updated: 2025-01-01
Tranexamic Acid as an Intervention in Abruptio Placenta
CompletedNCT05840471
Start: 2023-01-10End: 2024-02-10Updated: 2025-11-19
Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes & Follow-up Study
RecruitingNCT06427694
Start: 2024-06-01End: 2030-02-11Target: 60Updated: 2024-06-10